1
|
Pelletier R, Gicquel T, Carvelli J, Balaz P, Pelissier-Alicot AL, Morel I, Bottinelli C, Solas C, Le Daré B, Fabresse N. Severe 25E-NBOH intoxication associated with MDPHP intake: a case report, metabolism study, and literature review. Int J Legal Med 2024; 138:815-822. [PMID: 38117418 DOI: 10.1007/s00414-023-03151-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Accepted: 12/06/2023] [Indexed: 12/21/2023]
Abstract
N-Benzylphenethylamine derivatives are 5-HT2A receptor agonists with hallucinogenic properties, including NBOMe (N-(2-methoxybenzyl)-2-(3,4,5-trimethoxyphenyl)ethan-1-amine) and NBOH (2-(((2,5-dimethoxyphenethyl)amino)methyl)phenol). We reported here the case of a 23-year-old man who presented a serotoninergic syndrome and a loss of consciousness following the consumption of a powder labelled as 25I-NBOH. Toxicological analyses of biological samples were carried out using a liquid chromatography high-resolution mass spectrometry. Two new psychoactive substances were identified and confirmed with certified reference materials: 25E-NBOH (2-(((4-ethyl-2,5-dimethoxyphenethyl)amino)methyl)phenol) and MDPHP (1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one). Pharmaceuticals administered to the patient during his medical care were found in plasma and urine. 25E-NBOH and MDPHP concentrations were respectively at 2.3 ng/mL and 3.4 ng/mL in plasma, and 25.7 ng/mL and 30.5 ng/mL in urine. 25I-NBOH (2-(((4-iodo-2,5-dimethoxyphenethyl)amino)methyl)phenol) was specifically searched in both samples and was not detected. These results are discussed along with a literature review on human cases of exposure to N-benzylphenethylamine derivatives. Using molecular networking approach, we propose the first 25E-NBOH metabolism study using authentic biological samples (plasma and urine). We described seven metabolites (M1 to M7), including two phase I (m/z 330.172; m/z 288.160) and five phase II metabolites (m/z 464.191, m/z 478.207, m/z 492.223, m/z 508.218; m/z 396.156). The M6 (m/z 492.223) was the most intense ion detected in plasma and urine and could be proposed as a relevant 25E-NBOH consumption marker. Overall, we described an original case of 25E-NBOH poisoning and identified metabolites that could potentially be used as consumption markers to detect 25E-NBOH intoxications with a higher confidence level and probably a longer detection window.
Collapse
Affiliation(s)
- Romain Pelletier
- INSERM, INRAE, CHU Rennes, Institut NuMeCan (Nutrition, Metabolism and Cancer), PREVITOX Network, F-35033, Rennes, France.
- Rennes University Hospital, Clinical and Forensic Toxicology Laboratory, F-35033, Rennes, France.
| | - Thomas Gicquel
- INSERM, INRAE, CHU Rennes, Institut NuMeCan (Nutrition, Metabolism and Cancer), PREVITOX Network, F-35033, Rennes, France
- Rennes University Hospital, Clinical and Forensic Toxicology Laboratory, F-35033, Rennes, France
| | - Julien Carvelli
- AP-HM, DepaICMrtment of Intensive Care, Réanimation des Urgences, Medicine Intensive & Reanimation, Timone University Hospital, Marseille, France
| | - Pierre Balaz
- Bataillon des Marins Pompiers, Groupement Santé, Service Médical d'Urgence, 9 Boulevard de Strasbourg, 13233, Marseille Cedex 20, France
| | - Anne-Laure Pelissier-Alicot
- Aix Marseille Univ, APHM, INSERM, INMED UMR 901, La Timone University Hospital, Legal Medicine Department, 13005, Marseille, France
| | - Isabelle Morel
- INSERM, INRAE, CHU Rennes, Institut NuMeCan (Nutrition, Metabolism and Cancer), PREVITOX Network, F-35033, Rennes, France
- Rennes University Hospital, Clinical and Forensic Toxicology Laboratory, F-35033, Rennes, France
| | | | - Caroline Solas
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 rue Saint Pierre, 13385, Marseille Cedex 5, France
| | - Brendan Le Daré
- INSERM, INRAE, CHU Rennes, Institut NuMeCan (Nutrition, Metabolism and Cancer), PREVITOX Network, F-35033, Rennes, France
- Rennes University Hospital, Pharmacy department, F-35033, Rennes, France
| | - Nicolas Fabresse
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264 rue Saint Pierre, 13385, Marseille Cedex 5, France
- Aix Marseille University, INSERM, IRD, SESSTIM, Economic and Social Sciences of Health and Medical Information Processing, Marseille, France
| |
Collapse
|
2
|
Pelissier-Alicot AL, Ameline A, Kintz P, Adalian P, Leonetti G. Hair analysis in postmortem investigations: Case of a skeletonized body. Drug Test Anal 2024. [PMID: 38243699 DOI: 10.1002/dta.3649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Revised: 12/15/2023] [Accepted: 01/07/2024] [Indexed: 01/21/2024]
Abstract
Analysis of hair collected from putrefied or skeletal bodies is always complex and must take into account several pitfalls, such as external contamination and contamination by biological fluids. This work presents a case of particular complexity. A skeletonized body was discovered on a country road. A tuft of brown hair, detached from the scalp, irregular in length, non-oriented, in contact with soil and vegetation, was removed. An anthropological examination was carried out and genetic samples were taken from the right femoral shaft. After about 10 washes with warm water and dichloromethane, the tuft of hair was analyzed without segmentation. General unknown screening was performed by liquid chromatography system coupled to a high-resolution mass spectrometry (LC-HRMS) after incubation in pH 9.5 borate buffer and liquid-liquid extraction. Specific Multiple Reaction Monitoring (MRM) methods for date rape drugs were carried out by liquid chromatography system coupled to a tandem mass spectrometry (LC-MS/MS). The anthropological examination allowed to determine that the victim was a female individual, over 60 years old, the death dating from 3 months to 1 year. Comparison of the DNA results with the Missing Persons Index led to the identification, a 60-year-old woman who disappeared 5 months earlier. Hair analysis showed the presence of oxazepam (361 pg/mg), nordiazepam (54 pg/mg), and alimemazine (5 pg/mg). The interpretation of these concentrations is extremely difficult due to the risk of degradation of the hair cuticle during prolonged stay in the soil, as well as of contamination by putrefactive fluids. The authors discuss the value of using multiple biological and non-biological matrices in this context to improve the interpretation of the results.
Collapse
Affiliation(s)
| | | | - Pascal Kintz
- Institut de Médecine Légale, Strasbourg, France
- X-Pertise Consulting, Mittelhausbergen, France
| | | | - Georges Leonetti
- Service de Médecine Légale, Aix Marseille Univ, APHM, Hôpital La Timone, Marseille, France
| |
Collapse
|
3
|
Barré T, Venturino H, Di Beo V, Carrieri P, Pelissier-Alicot AL. French general practitioners and medical cannabis: A need for training. Encephale 2023; 49:537-539. [PMID: 37246101 DOI: 10.1016/j.encep.2023.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Accepted: 04/12/2023] [Indexed: 05/30/2023]
Affiliation(s)
- Tangui Barré
- Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
| | - Hélène Venturino
- Aix-Marseille Université, Faculté de Médecine, Marseille, France.
| | - Vincent Di Beo
- Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
| | - Patrizia Carrieri
- Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
| | - Anne-Laure Pelissier-Alicot
- APHM, CHU La Timone, Service de Médecine légale, Aix-Marseille Université, Faculté de Médecine, Marseille, France.
| |
Collapse
|
4
|
Bernabeu A, Bara A, Murphy Green MN, Manduca A, Wager-Miller J, Borsoi M, Lassalle O, Pelissier-Alicot AL, Chavis P, Mackie K, Manzoni OJ. Sexually Dimorphic Adolescent Trajectories of Prefrontal Endocannabinoid Synaptic Plasticity Equalize in Adulthood, Reflected by Endocannabinoid System Gene Expression. Cannabis Cannabinoid Res 2023; 8:749-767. [PMID: 37015060 PMCID: PMC10701511 DOI: 10.1089/can.2022.0308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/06/2023] Open
Abstract
Introduction: How sex influences prefrontal cortexes (PFCs) synaptic development through adolescence remains unclear. Materials and Methods: In this study we describe sex-specific cellular and synaptic trajectories in the rat PFC from adolescence to adulthood. Results: The excitability of PFC layer 5 pyramidal neurons was lower in adult females compared with other developmental stages. The developmental course of endocannabinoid-mediated long-term depression (eCB-LTD) was sexually dimorphic, unlike long-term potentiation or mGluR3-LTD. eCB-LTD was expressed in juvenile females but appeared only at puberty in males. Endovanilloid TRPV1R or eCB receptors were engaged during LTD in a sequential and sexually dimorphic manner. Gene expression of the eCB/vanilloid systems was sequential and sex specific. LTD-incompetent juvenile males had elevated expression levels of the CB1R-interacting inhibitory protein cannabinoid receptor interacting protein 1a and of the 2-arachidonoylglycerol-degrading enzyme ABHD6. Pharmacological inhibition of ABHD6 or MAGL enabled LTD in young males, whereas inhibition of anandamide degradation was ineffective. Conclusions: These results reveal sex differences in the maturational trajectories of the rat PFC.
Collapse
Affiliation(s)
- Axel Bernabeu
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
| | - Anissa Bara
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
| | - Michelle N. Murphy Green
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
- The Gill Center for Biomolecular Science and Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA
| | - Antonia Manduca
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
| | - Jim Wager-Miller
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
- The Gill Center for Biomolecular Science and Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA
| | - Milene Borsoi
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
| | - Olivier Lassalle
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
| | - Anne-Laure Pelissier-Alicot
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
- APHM, CHU Timone Adultes, Service de Médecine Légale, Marseille, France
| | - Pascale Chavis
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
| | - Ken Mackie
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
- The Gill Center for Biomolecular Science and Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA
| | - Olivier J.J. Manzoni
- INMED, INSERM U1249, Marseille, France
- Aix-Marseille University, Marseille, France
- Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Bloomington, Indiana, USA
| |
Collapse
|
5
|
Becam J, Pelissier-Alicot AL, Doudka N, Richez M, Solas C, Fabresse N. Validation of a non-targeted method devoted to identification and quantitation of toxicologically relevant compounds in plasma with HRMS. J Chromatogr B Analyt Technol Biomed Life Sci 2023; 1224:123739. [PMID: 37172558 DOI: 10.1016/j.jchromb.2023.123739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 04/13/2023] [Accepted: 05/02/2023] [Indexed: 05/15/2023]
Abstract
The objective of this study was to develop and validate a simple method using liquid chromatography hyphenated to high resolution mass spectrometry (HRMS) allowing both the performance of a non-targeted screening and the simultaneous quantification of 29 compounds of interest in clinical and forensic toxicology. Extraction was done with QuEChERS salts and acetonitrile, after addition of internal standard to 200 μL of human plasma samples. The mass spectrometer was an Orbitrap, with a heated electrospray ionization (HESI) probe. The analyses were carried out in full scan experiment with a nominal resolving power of 60,000 FWHM within the 125-650 m/z mass range, followed by four cycles of data dependent analysis (DDA) with a mass resolution of 16,000 FWHM. The untargeted screening was evaluated using 132 compounds, mean limit of identification (LOI) was 8.8 ng/mL (min = 0.05 ng/mL, max = 500 ng/mL) and mean limit of detection (LOD) was 0.25 ng/mL (min = 0.05 ng/mL, max = 5 ng/mL). The method was linear in the 5 to 500 ng/mL range (0.5 to 50 ng/mL for cannabinoids, 6-acetylmorphine and buprenorphine) with correlation coefficients > 0.99, intra- and inter-day accuracy and precision were < 15% for all compounds. The method was successfully applied to 31 routine samples.
Collapse
Affiliation(s)
- Jenny Becam
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264, rue Saint Pierre, 13385 Marseille Cedex 5, France
| | | | - Natalia Doudka
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264, rue Saint Pierre, 13385 Marseille Cedex 5, France
| | - Magali Richez
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264, rue Saint Pierre, 13385 Marseille Cedex 5, France
| | - Caroline Solas
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264, rue Saint Pierre, 13385 Marseille Cedex 5, France
| | - Nicolas Fabresse
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, 264, rue Saint Pierre, 13385 Marseille Cedex 5, France; Aix Marseille University, INSERM, IRD, SESSTIM, Economic and Social Sciences of Health and Medical Information Processing, 27 Bd Jean Moulin, 13385 Marseille, France.
| |
Collapse
|
6
|
Barré T, Venturino H, Di Beo V, Carrieri P, Pelissier-Alicot AL. Exploring the medical cannabis prescribing behaviours of French general practitioners. Drug Alcohol Rev 2023; 42:299-303. [PMID: 36196529 DOI: 10.1111/dar.13547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 08/25/2022] [Accepted: 08/25/2022] [Indexed: 02/03/2023]
Affiliation(s)
- Tangui Barré
- Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Hélène Venturino
- Aix-Marseille Université, Faculté de Médecine, Marseille, France
| | - Vincent Di Beo
- Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Patrizia Carrieri
- Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Anne-Laure Pelissier-Alicot
- APHM, CHU La Timone, Service de Médecine légale, Aix-Marseille Université, Faculté de Médecine, Marseille, France
| |
Collapse
|
7
|
Fabresse N, Faltot M, Roux P, Becam J, Doudon E, Lacarelle B, Solas C, Pelissier-Alicot AL. Determination of cannabinoids content in light cannabis inflorescences sold in France. Drug Test Anal 2023. [PMID: 36597181 DOI: 10.1002/dta.3436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2022] [Revised: 12/22/2022] [Accepted: 12/28/2022] [Indexed: 01/05/2023]
Abstract
In the last 2 years, the number of shops selling CBD-rich THC-deprived cannabis flowers (CrTd) has increased considerably in France as in many European countries. The objective of this study was to determine the actual composition of the samples sold in these stores and to discuss regulatory consequences that may affect users. Samples were provided from shops in the region Provence-Alpes Cote d'Azur (PACA), France. Pictures of the samples were taken before they were weighed then crushed. Twenty milligrams were diluted in 10 ml heptane ethyl acetate (7:1; v:v) for analysis by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method was validated according to SWGTOX guidelines for the quantification of cannabidiol (CBD), delta-9-tetrahydrocannabinol (THC) and cannabinol (CBN). Thirty-nine samples obtained between November 2021 and January 2022 in the PACA region were analyzed in this study. Mean content was 0.32% (0.03%-0.77%; STDV = 0.17%; n = 39) for THC, 2.23% (0.01%-5.97%; STDV = 1.29%; n = 39) for CBD and 0.01% (0.004%-0.025%; STDV = 0.01%; n = 19) for CBN. THC content over the threshold defined by the European legislation (>0.3%) was found in 18 of the 39 samples analyzed together with a CBD content <1% in nine samples (23%). None of the products analyzed had health risk messages on the packaging. The consumption of these products may lead to the presence of THC in biological fluids, which can be detected by screening. Users may then find themselves in breach of the law particularly when driving. Consumers should therefore be informed both about the actual composition of these products and about the legal and health risks they run.
Collapse
Affiliation(s)
- Nicolas Fabresse
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, Marseille, France.,Aix Marseille University, INSERM, IRD, SESSTIM, Economic and Social Sciences of Health and Medical Information Processing, Marseille, France
| | - Marc Faltot
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, Marseille, France
| | - Perrine Roux
- Aix Marseille University, INSERM, IRD, SESSTIM, Economic and Social Sciences of Health and Medical Information Processing, Marseille, France
| | - Jenny Becam
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, Marseille, France
| | - Emilie Doudon
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, Marseille, France
| | - Bruno Lacarelle
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, Marseille, France
| | - Caroline Solas
- Laboratory of Pharmacokinetics and Toxicology, La Timone University Hospital, Marseille, France
| | | |
Collapse
|
8
|
Mezaache S, Diarra C, Pochard L, Spadari M, Becam J, Fabresse N, Pelissier-Alicot AL, Frauger E, Micallef J. Complications sanitaires observées chez des consommateurs de clonazépam et prégabaline. Therapie 2022. [DOI: 10.1016/j.therap.2022.10.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
9
|
Pelissier-Alicot AL, Fabresse N, Sastre C, Baillif-Couniou V, Becam J, Leonetti G. Deaths related to the combination of pregabalin and other drugs of abuse: About two cases. Toxicologie Analytique et Clinique 2022. [DOI: 10.1016/j.toxac.2022.06.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
10
|
Zerdazi EH, Curis E, Karsinti E, Icick R, Fortias M, Batel P, Cottencin O, Orizet C, Gay A, Coeuru P, Deschenau A, Lack P, Moisan D, Pelissier-Alicot AL, Plat A, Trabut JB, Kousignian I, Boumendil L, Vicaut E, Prince N, Laplanche JL, Bellivier F, Lépine JP, Marie-Claire C, Brousse G, Vorspan F, Bloch V. Occurrence and severity of cocaine-induced hallucinations: Two distinct phenotypes with shared clinical factors but specific genetic risk factors. Drug Alcohol Depend 2022; 232:109270. [PMID: 35124387 DOI: 10.1016/j.drugalcdep.2022.109270] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2021] [Revised: 01/03/2022] [Accepted: 01/03/2022] [Indexed: 11/15/2022]
Abstract
UNLABELLED Cocaine-induced transient hallucinations (CIH) are a frequent complication following cocaine intake that is associated with addiction severity. METHODS Two hundred and forty-two non-psychotic and Caucasian lifetime cocaine users were included in a French multicentric study. Clinical variables and dopamine pathway genotype data were extracted and tested with CIH scores using a zero-inflated binomial model, which allows for the exploration of factors associated with occurrence and severity separately. RESULTS Cocaine dependence (poccurrence= 6.18 × 10-5, pseverity= 9.25 × 10-8), number of cocaine dependence DSM IV-Tr criteria (poccurrence= 1.22 × 10-7, pseverity= 5.09 × 10-6), and frequency of intake during the worst period of misuse (poccurrence= 8.51 × 10-04, pseverity= 0.04) were associated with greater occurrence and higher severity of CIH. The genetic associations did not yield significant results after correction for multiple tests. However, some nominal associations of SNPs mapped to the VMAT2, DBH, DRD1, and DRD2 genes were significant. In the multivariate model, the significant variables were the number of cocaine dependence criteria, lifetime alcohol dependence, and the nominally associated SNPs. CONCLUSION Our study shows that CIH occurrence and severity are two distinct phenotypes, with shared clinical risk factors; however, they likely do not share the same genetic background.
Collapse
Affiliation(s)
- El-Hadi Zerdazi
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, Hôpitaux Universitaires Henri Mondor, DMU IMPACT, Hôpital Emile ROUX, Service d'addictologie, Limeil Brévannes 94450, France.
| | - Emmanuel Curis
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; EA 7537 BioSTM, Faculté de Pharmacie, Université Paris Descartes, USPC, Paris 75006, France
| | - Emily Karsinti
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, GHU Nord-Université de Paris, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologigue, Paris 75010, France; Université Paris Nanterre, Laboratoire Clipsyd, Nanterre 92000, France
| | - Romain Icick
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, GHU Nord-Université de Paris, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologigue, Paris 75010, France
| | - Maeva Fortias
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, GHU Nord-Université de Paris, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologigue, Paris 75010, France
| | - Philippe Batel
- Centre Hospitalier Camille Claudel, Service d'Addictologie de la Charente, La Couronne 16400, France
| | - Olivier Cottencin
- University of Lille, Inserm U-1172, CHU Lille, Department of Psychiatry and Addiction Medicine, Lille 59000, France
| | - Cyrille Orizet
- APHP, GHU Centre-Université de Paris, Hôpital Européen Georges Pompidou, CSAPA Monte-Cristo, Paris 75015, France
| | - Aurélia Gay
- CHU Saint-Etienne, Service d'Addictologie, Saint-Etienne 42000, France
| | | | - Alice Deschenau
- Hôpital Paul Guiraud, CSAPA Clinique Liberté, Ivry-sur-Seine 94200, France
| | - Philippe Lack
- Hôpital de la Croix Rousse, CSAPA, Lyon 69004, France
| | - Delphine Moisan
- APHP, GHU Nord-Université de Paris, Hôpital Beaujon, UTAMA, Clichy 92110, France
| | - Anne-Laure Pelissier-Alicot
- APHM, CHU La Timone, Service de Médecine légale, Aix-Marseille Université, Faculté de Médecine, Marseille 13385, France
| | - Arnaud Plat
- APHP, GHU Nord-Université de Paris, Hôpital Beaujon, UTAMA, Clichy 92110, France
| | - Jean-Baptiste Trabut
- APHP, Hôpitaux Universitaires Henri Mondor, DMU IMPACT, Hôpital Emile ROUX, Service d'addictologie, Limeil Brévannes 94450, France
| | - Isabelle Kousignian
- EA 7537 BioSTM, Faculté de Pharmacie, Université Paris Descartes, USPC, Paris 75006, France
| | - Luana Boumendil
- EA 7537 BioSTM, Faculté de Pharmacie, Université Paris Descartes, USPC, Paris 75006, France
| | - Eric Vicaut
- APHP, GHU Nord-Université de Paris, Hôpital Fernand Widal, Unité de Recherche Clinique, Paris 75010, France
| | - Nathalie Prince
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France
| | - Jean-Louis Laplanche
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, GHU Nord-Université de Paris, Hôpital Lariboisière, DMU BioGeM, Département de Biochimie et Biologie Moléculaire, Paris 75010, France
| | - Frank Bellivier
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, GHU Nord-Université de Paris, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologigue, Paris 75010, France
| | - Jean-Pierre Lépine
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France
| | - Cynthia Marie-Claire
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France
| | - Georges Brousse
- CHU Clermont-Ferrand, Hôpital Gabriel Montpied, Service d'Addictologie et Université d'Auvergne EA 7280, UFR de Médecine, Clermont-Ferrand 63000, France
| | - Florence Vorspan
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, GHU Nord-Université de Paris, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologigue, Paris 75010, France
| | - Vanessa Bloch
- Université de Paris, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris F-75006, France; APHP, GHU Nord-Université de Paris, Hôpital Fernand Widal, Pharmacie Hospitalière, Paris 75010, France
| |
Collapse
|
11
|
Icick R, Karsinti E, Brousse G, Chrétienneau C, Trabut JB, Belforte B, Coeuru P, Moisan D, Deschenau A, Cottencin O, Gay A, Lack P, Pelissier-Alicot AL, Dupuy G, Fortias M, Etain B, Lépine JP, Laplanche JL, Bellivier F, Vorspan F, Bloch V. Childhood trauma and the severity of past suicide attempts in outpatients with cocaine use disorders. Subst Abus 2021; 43:623-632. [PMID: 34597243 DOI: 10.1080/08897077.2021.1975875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Suicide attempts have been associated with both cocaine use disorder (CocUD) and childhood trauma. We investigated how childhood trauma is an independent risk factor for serious and recurrent suicide attempts in CocUD. Method: 298 outpatients (23% women) with CocUD underwent standardized assessments of substance dependence (Diagnostic and Statistical Manual-mental disorders, fourth edition, text revised), impulsiveness, resilience, and childhood trauma, using validated tools. Suicide attempts history was categorized as single vs. recurrent or non-serious vs. serious depending on the lifetime number of suicide attempts and the potential or actual lethality of the worst attempt reported, respectively. Bivariate and multinomial regression analyses were used to characterize which childhood trauma patterns were associated with the suicide attempts groups. Results: 58% of CocUD patients reported childhood trauma. Recurrent and serious suicide attempts clustered together and were thus combined into "severe SA." Severe suicide attempt risk increased proportionally to the number of childhood traumas (test for trend, p = 9 × 10-7). Non-severe suicide attempt risk increased with impulsiveness and decreased with resilience. In multinomial regression models, a higher number of traumas and emotional abuse were independently and only associated with severe vs. non-severe suicide attempts (effect size = 0.82, AUC = 0.7). The study was limited by its cross-sectional design. Conclusion: These preferential associations between childhood trauma and severe suicide attempts warrant specific monitoring of suicide attempts risk in CocUD, regardless of the severity of addiction profiles.
Collapse
Affiliation(s)
- Romain Icick
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,INSERM UMR-S1144, Université de Paris, Paris, France
| | - Emily Karsinti
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,ED139, Laboratoire CLIPSYD, Paris Nanterre University, Nanterre, France
| | - Georges Brousse
- INSERM UMR-1107, Neuro-Dol, Université Clermont-Auvergne, Clermont-Ferrand, France
| | - Clara Chrétienneau
- INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France
| | | | - Beatriz Belforte
- APHP, Hôpital Européen Georges Pompidou, CSAPA Monte-Cristo, Paris, France
| | | | | | | | - Olivier Cottencin
- Université de Lille, CHU Lille - Psychiaty and Addiction Medicine Department, INSERM U1172 - Lille Neuroscience & Cognition Centre (LiNC), Plasticity & SubjectivitY team, Lille, France
| | - Aurélia Gay
- Service d'Addictologie, CHU St Etienne, Saint Etienne, France
| | | | | | - Gaël Dupuy
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France
| | - Maeva Fortias
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France
| | - Bruno Etain
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,INSERM UMR-S1144, Université de Paris, Paris, France
| | - Jean-Pierre Lépine
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,INSERM UMR-S1144, Université de Paris, Paris, France
| | - Jean-Louis Laplanche
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,INSERM UMR-S1144, Université de Paris, Paris, France
| | - Frank Bellivier
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,INSERM UMR-S1144, Université de Paris, Paris, France
| | - Florence Vorspan
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,INSERM UMR-S1144, Université de Paris, Paris, France
| | - Vanessa Bloch
- Département de Psychiatrie et de Médecine Addictologique, Assistance Publique - Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.,INSERM U1144, "Therapeutic Optimization in Neuropsychopharmacology", Paris, France.,INSERM UMR-S1144, Université de Paris, Paris, France
| |
Collapse
|
12
|
Pelissier-Alicot AL, Gaulier JM, Fournier PE, Gish A, Sastre C, Baillif-Couniou V, Reynoard J, Champeaux C, Piercecchi MD, Léonetti G. Interprétation des cyanures dans le sang post-mortem : à propos d’un cas. Toxicologie Analytique et Clinique 2021. [DOI: 10.1016/j.toxac.2021.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
13
|
Castel P, Barbier M, Poumerol E, Mandon-Pépin B, Tassistro V, Lepidi H, Pelissier-Alicot AL, Manzoni OJ, Courbiere B. Prenatal cannabinoid exposure alters the ovarian reserve in adult offspring of rats. Arch Toxicol 2020; 94:4131-4141. [PMID: 32833042 DOI: 10.1007/s00204-020-02877-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2020] [Accepted: 08/12/2020] [Indexed: 12/15/2022]
Abstract
In animals, research in the past two decades has demonstrated the strong involvement of the endocannabinoid system (ECS) in numerous steps of the reproductive process, including ovarian physiology. Reproductive lifespan is closely related to the number of nongrowing ovarian follicles, called ovarian reserve (OR), which is definitively established during foetal life. Thus, OR damage may lead to poor reproductive outcomes and a shortened reproductive lifespan. We investigated whether prenatal ECS modulation had an effect on the OR at different ages in the rat offspring. Four groups of gestating female rats (F0) were exposed to the CB1-/CB2-receptor agonist WIN55212 (0.5 mg/kg), the CB1R inverse agonist SR141716 (3 mg/kg) or Δ9THC (5 mg/kg) and were compared to negative control groups. OR was histologically assessed at different postnatal timepoints (F1 individuals): postnatal day (PND) 6, PND40 and PND90. At PND6, prenatal exposure had no effect on OR. In the young adult group (PND90) exposed during gestation to WIN55212, we observed a CB1R-mediated delayed OR decrease, which was reversed by prenatal CB1R blockade by SR141716. Conversely, after prenatal SR141716 exposure, we observed higher OR counts at PND90. RT-PCR experiments also showed that prenatal ECS modulation perturbed the mRNA levels of ECS enzymes and OR regulation genes. Our findings support the role of the ECS in OR regulation during the foetal life of rats and highlight the need for further studies to elucidate its precise role in OR physiology.
Collapse
Affiliation(s)
- Pierre Castel
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE, Marseille, France. .,Aix Marseille Univ, IMBE, CHU Conception, Service de Gynécologie-Obstétrique, Marseille, France.
| | - Magalie Barbier
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE, Marseille, France
| | - Elodie Poumerol
- UMR BDR, INRA, ENVA, Université Paris Saclay, Jouy-en-Josas, 78350, France
| | | | - Virginie Tassistro
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE, Marseille, France
| | - Hubert Lepidi
- Aix Marseille Univ, APHM, Laboratoire d'anatomie pathologique, Marseille, France
| | - Anne-Laure Pelissier-Alicot
- INMED, INSERM U1249, Marseille, France.,Aix-Marseille University, Marseille, France.,Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Marseille, France.,Aix Marseille Univ, APHM, CHU Timone, Service de Medecine Legale, Marseille, France
| | - Olivier J Manzoni
- INMED, INSERM U1249, Marseille, France.,Aix-Marseille University, Marseille, France.,Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Aix-Marseille University/Indiana University, Marseille, France
| | - Blandine Courbiere
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE, Marseille, France.,Aix Marseille Univ, IMBE, CHU Conception, Service de Gynécologie-Obstétrique, Marseille, France
| |
Collapse
|
14
|
Scheyer AF, Borsoi M, Wager-Miller J, Pelissier-Alicot AL, Murphy MN, Mackie K, Manzoni OJJ. Cannabinoid Exposure via Lactation in Rats Disrupts Perinatal Programming of the Gamma-Aminobutyric Acid Trajectory and Select Early-Life Behaviors. Biol Psychiatry 2020; 87:666-677. [PMID: 31653479 PMCID: PMC7056509 DOI: 10.1016/j.biopsych.2019.08.023] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/23/2019] [Revised: 08/26/2019] [Accepted: 08/26/2019] [Indexed: 01/22/2023]
Abstract
BACKGROUND Cannabis usage is increasing with its widespread legalization. Cannabis use by mothers during lactation transfers active cannabinoids to the developing offspring during this critical period and alters postnatal neurodevelopment. A key neurodevelopmental landmark is the excitatory to inhibitory gamma-aminobutyric acid (GABA) switch caused by reciprocal changes in expression ratios of the K+/Cl- transporters potassium-chloride cotransporter 2 (KCC2) and sodium-potassium-chloride transporter (NKCC1). METHODS Rat dams were treated with Δ9-tetrahydrocannabinol or a synthetic cannabinoid during the first 10 days of postnatal development, and experiments were then conducted in the offspring exposed to these drugs via lactation. The network influence of GABA transmission was analyzed using cell-attached recordings. KCC2 and NKCC1 levels were determined using Western blot and quantitative polymerase chain reaction analyses. Ultrasonic vocalization and homing behavioral experiments were carried out at relevant time points. RESULTS Treating rat dams with cannabinoids during early lactation retards transcriptional upregulation and expression of KCC2, thereby delaying the GABA switch in pups of both sexes. This perturbed trajectory was corrected by the NKCC1 antagonist bumetanide and accompanied by alterations in ultrasonic vocalization without changes in homing behavior. Neurobehavioral deficits were prevented by CB1 receptor antagonism during maternal exposure, showing that the CB1 receptor underlies the cannabinoid-induced alterations. CONCLUSIONS These results reveal how perinatal cannabinoid exposure retards an early milestone of development, delaying the trajectory of GABA's polarity transition and altering early-life communication.
Collapse
Affiliation(s)
- Andrew F Scheyer
- Institut de neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale U1249, Marseille, France; Aix-Marseille University, Marseille, France; Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University
| | - Milene Borsoi
- Institut de neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale U1249, Marseille, France; Aix-Marseille University, Marseille, France; Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University
| | - Jim Wager-Miller
- Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University; Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana; Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana
| | - Anne-Laure Pelissier-Alicot
- Institut de neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale U1249, Marseille, France; Aix-Marseille University, Marseille, France; Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University; Service de Psychiatrie, CHU Conception, Assistance Publique - Hôpitaux de Marseille, Marseille, France; Service de Médecine Légale, CHU Timone-Adultes, Assistance Publique - Hôpitaux de Marseille, Marseille, France
| | - Michelle N Murphy
- Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University; Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana; Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana
| | - Ken Mackie
- Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University; Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana; Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.
| | - Olivier J J Manzoni
- Institut de neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale U1249, Marseille, France; Aix-Marseille University, Marseille, France; Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University.
| |
Collapse
|
15
|
Pelissier-Alicot AL, Kintz P, Ameline A, Bosdure E, Chabrol B, Neant N, Torrents R, Sastre C, Baillif-Couniou V, Tuchtan-Torrents L, Leonetti G. Bromazepam intoxication in an infant: Contribution of hair and nail analysis. Drug Test Anal 2020; 12:397-401. [PMID: 31997564 DOI: 10.1002/dta.2774] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2019] [Revised: 01/27/2020] [Accepted: 01/27/2020] [Indexed: 02/05/2023]
Affiliation(s)
| | - Pascal Kintz
- Laboratoire de Toxicologie, Institut de Médecine Légale, Strasbourg, France
| | - Alice Ameline
- Laboratoire de Toxicologie, Institut de Médecine Légale, Strasbourg, France
| | - Emmanuelle Bosdure
- Aix Marseille University, APHM, Hôpital La Timone, Service de Pédiatrie Spécialisée et de Médecine Infantile, Marseille, France
| | - Brigitte Chabrol
- Aix Marseille University, APHM, Hôpital La Timone, Service de Pédiatrie Spécialisée et de Médecine Infantile, Marseille, France
| | - Nadège Neant
- Laboratoire de Pharmacocinétique et Toxicologie, Aix Marseille University, APHM, INSERM, CNRS, CRCM SMARTc, Hôpital La Timone, Marseille, France
| | - Romain Torrents
- Aix Marseille University, APHM, Hôpitaux Sud, Pharmacologie Toxicologie Clinique - Centre Anti-Poison et de ToxicoVigilance (CAP-TV), Marseille, France
| | - Caroline Sastre
- Service de Médecine Légale, Aix Marseille University, APHM, Hôpital La Timone, Marseille, France
| | - Valérie Baillif-Couniou
- Service de Médecine Légale, Aix Marseille University, APHM, Hôpital La Timone, Marseille, France
| | - Lucile Tuchtan-Torrents
- Service de Médecine Légale, Aix Marseille University, APHM, Hôpital La Timone, Marseille, France
| | - Georges Leonetti
- Service de Médecine Légale, Aix Marseille University, APHM, Hôpital La Timone, Marseille, France
| |
Collapse
|
16
|
Abstract
BACKGROUND Drug concentrations obtained from post mortem samples do not necessarily reflect the concentrations at the time of death, and variations of concentration may be observed between different sites and/or different sampling times. These phenomena, collectively termed post mortem redistribution, concern numerous molecules (medications, drugs of abuse, gases, etc.) and can complicate the interpretation of toxicological analyses. METHODS Literature review. RESULTS The mechanisms that cause these phenomena are complex and often intricate. Certain organs, which concentrate the molecules before death, may release them very early in the vascular sector. The gastrointestinal tract, liver, lungs and myocardium are mainly concerned. Cell autolysis also plays a part in drug release. Furthermore, micro-organisms (mainly bacteria and yeasts) which colonize the organism during putrefaction may cause neoformation and/or the degradation of certain molecules. Lastly, it appears that the physicochemical and pharmacokinetic profile of xenobiotics, notably their lipophilic nature, their ionization state and their volume of distribution may be factors likely to influence redistribution phenomena. Some recommendations concerning anatomic sampling sites, sampling methods and sample storage make it possible to limit these phenomena.
Collapse
Affiliation(s)
- Caroline Sastre
- APHM, Hôpital de la Timone, Service de Médecine Légale, Marseille, France
| | - Christophe Bartoli
- Aix-Marseille Univ, APHM, Hôpital de la Timone, Service de Médecine Légale, Marseille, France
| | | | - Georges Leonetti
- APHM, Hôpital de la Timone, Service de Médecine Légale, Marseille, France.,Aix-Marseille Univ, APHM, Hôpital de la Timone, Service de Médecine Légale, Marseille, France
| | - Anne-Laure Pelissier-Alicot
- APHM, Hôpital de la Timone, Service de Médecine Légale, Marseille, France.,Aix-Marseille Univ, APHM, Hôpital de la Timone, Service de Médecine Légale, Marseille, France
| |
Collapse
|
17
|
Borsoi M, Manduca A, Bara A, Lassalle O, Pelissier-Alicot AL, Manzoni OJ. Sex Differences in the Behavioral and Synaptic Consequences of a Single in vivo Exposure to the Synthetic Cannabimimetic WIN55,212-2 at Puberty and Adulthood. Front Behav Neurosci 2019; 13:23. [PMID: 30890922 PMCID: PMC6411818 DOI: 10.3389/fnbeh.2019.00023] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Accepted: 01/30/2019] [Indexed: 01/08/2023] Open
Abstract
Heavy cannabis consumption among adolescents is associated with significant and lasting neurobiological, psychological and health consequences that depend on the age of first use. Chronic exposure to cannabinoid agonists during the perinatal period or adolescence alters social behavior and prefrontal cortex (PFC) activity in adult rats. However, sex differences on social behavior as well as PFC synaptic plasticity after acute cannabinoid activation remain poorly explored. Here, we determined that the consequences of a single in vivo exposure to the synthetic cannabimimetic WIN55,212-2 differently affected PFC neuronal and synaptic functions after 24 h in male and female rats during the pubertal and adulthood periods. During puberty, single cannabinoid exposure (SCE) reduced play behavior in females but not males. In contrast, the same treatment impaired sociability in both sexes at adulthood. General exploration and memory recognition remained normal at both ages and both sexes. At the synaptic level, SCE ablated endocannabinoid-mediated synaptic plasticity in the PFC of females of both ages and heightened excitability of PFC pyramidal neurons at adulthood, while males were spared. In contrast, cannabinoid exposure was associated with impaired long-term potentiation (LTP) specifically in adult males. Together, these data indicate behavioral and synaptic sex differences in response to a single in vivo exposure to cannabinoid at puberty and adulthood.
Collapse
Affiliation(s)
- Milene Borsoi
- Aix Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Neurobiologie de la Méditerranée (INMED), Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Indiana University, Marseille, France
| | - Antonia Manduca
- Aix Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Neurobiologie de la Méditerranée (INMED), Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Indiana University, Marseille, France
| | - Anissa Bara
- Aix Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Neurobiologie de la Méditerranée (INMED), Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Indiana University, Marseille, France
| | - Olivier Lassalle
- Aix Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Neurobiologie de la Méditerranée (INMED), Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Indiana University, Marseille, France
| | - Anne-Laure Pelissier-Alicot
- Aix Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Neurobiologie de la Méditerranée (INMED), Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Indiana University, Marseille, France.,Assistance Publique Hôpitaux de Marseille (APHM), CHU Conception, Service de Psychiatrie, Marseille, France.,Assistance Publique Hôpitaux de Marseille (APHM), CHU Timone Adultes, Service de Médecine Légale, Marseille, France
| | - Olivier J Manzoni
- Aix Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Neurobiologie de la Méditerranée (INMED), Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, INSERM-Indiana University, Marseille, France
| |
Collapse
|
18
|
Bara A, Manduca A, Bernabeu A, Borsoi M, Serviado M, Lassalle O, Murphy M, Wager-Miller J, Mackie K, Pelissier-Alicot AL, Trezza V, Manzoni OJ. Sex-dependent effects of in utero cannabinoid exposure on cortical function. eLife 2018; 7:36234. [PMID: 30201092 PMCID: PMC6162091 DOI: 10.7554/elife.36234] [Citation(s) in RCA: 66] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2018] [Accepted: 08/15/2018] [Indexed: 12/11/2022] Open
Abstract
Cannabinoids can cross the placenta, thus may interfere with fetal endocannabinoid signaling during neurodevelopment, causing long-lasting deficits. Despite increasing reports of cannabis consumption during pregnancy, the protracted consequences of prenatal cannabinoid exposure (PCE) remain incompletely understood. Here, we report sex-specific differences in behavioral and neuronal deficits in the adult progeny of rat dams exposed to low doses of cannabinoids during gestation. In males, PCE reduced social interaction, ablated endocannabinoid long-term depression (LTD) and heightened excitability of prefrontal cortex pyramidal neurons, while females were spared. Group 1 mGluR and endocannabinoid signaling regulate emotional behavior and synaptic plasticity. Notably, sex-differences following PCE included levels of mGluR1/5 and TRPV1R mRNA. Finally, positive allosteric modulation of mGlu5 and enhancement of anandamide levels restored LTD and social interaction in PCE adult males. Together, these results highlight marked sexual differences in the effects of PCE and introduce strategies for reversing detrimental effects of PCE.
Collapse
Affiliation(s)
- Anissa Bara
- Aix Marseille University, INSERM, INMED, Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States
| | - Antonia Manduca
- Aix Marseille University, INSERM, INMED, Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States.,Section of Biomedical Sciences and Technologies, Department of Science, University Roma Tre, Rome, Italy
| | - Axel Bernabeu
- Aix Marseille University, INSERM, INMED, Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States.,APHM, CHU Conception, Service de Psychiatrie, Marseille, France
| | - Milene Borsoi
- Aix Marseille University, INSERM, INMED, Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States
| | - Michela Serviado
- Section of Biomedical Sciences and Technologies, Department of Science, University Roma Tre, Rome, Italy
| | - Olivier Lassalle
- Aix Marseille University, INSERM, INMED, Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States
| | - Michelle Murphy
- Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States.,Department of Psychological and Brain Sciences, Indiana University, Bloomington, United States.,Gill Centre, Indiana University, Bloomington, United States
| | - Jim Wager-Miller
- Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States.,Department of Psychological and Brain Sciences, Indiana University, Bloomington, United States.,Gill Centre, Indiana University, Bloomington, United States
| | - Ken Mackie
- Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States.,Department of Psychological and Brain Sciences, Indiana University, Bloomington, United States.,Gill Centre, Indiana University, Bloomington, United States
| | - Anne-Laure Pelissier-Alicot
- Aix Marseille University, INSERM, INMED, Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States.,APHM, CHU Conception, Service de Psychiatrie, Marseille, France.,APHM, CHU Timone Adultes, Service de Médecine Légale, Marseille, France
| | - Viviana Trezza
- Section of Biomedical Sciences and Technologies, Department of Science, University Roma Tre, Rome, Italy
| | - Olivier J Manzoni
- Aix Marseille University, INSERM, INMED, Marseille, France.,Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory, Indiana University, Indiana, United States
| |
Collapse
|
19
|
Bartoli C, Berland-Benhaim C, Tuchtan-Torrents L, Kintz P, Leonetti G, Pelissier-Alicot AL. Suicide by Medication Overdose in Prison: A Study of Three Cases. J Forensic Sci 2017; 63:1316-1320. [DOI: 10.1111/1556-4029.13671] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2017] [Revised: 09/28/2017] [Accepted: 09/28/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Christophe Bartoli
- CNRS; EFS; ADES; Aix Marseille Univ; Marseille France
- Service de Médecine Légale; APHM, CHU Timone; Marseille France
| | | | - Lucile Tuchtan-Torrents
- CNRS; EFS; ADES; Aix Marseille Univ; Marseille France
- Service de Médecine Légale; APHM, CHU Timone; Marseille France
| | - Pascal Kintz
- X-Pertise Consulting; 84 route de Saverne 67205 Oberhausbergen France
- IML; Strasbourg France
| | - Georges Leonetti
- CNRS; EFS; ADES; Aix Marseille Univ; Marseille France
- Service de Médecine Légale; APHM, CHU Timone; Marseille France
| | - Anne-Laure Pelissier-Alicot
- Service de Médecine Légale; APHM, CHU Timone; Marseille France
- INSERM; INMED; 1 Aix Marseille Univ, CNRS, EFS, ADES; Marseille France
| |
Collapse
|
20
|
Martin HGS, Bernabeu A, Lassalle O, Bouille C, Beurrier C, Pelissier-Alicot AL, Manzoni OJ. Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex. Front Cell Neurosci 2015; 9:457. [PMID: 26648844 PMCID: PMC4664641 DOI: 10.3389/fncel.2015.00457] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2015] [Accepted: 11/09/2015] [Indexed: 12/31/2022] Open
Abstract
Cholinergic inputs into the prefrontal cortex (PFC) are associated with attention and cognition; however there is evidence that acetylcholine also has a role in PFC dependent learning and memory. Muscarinic acetylcholine receptors (mAChR) in the PFC can induce synaptic plasticity, but the underlying mechanisms remain either opaque or unresolved. We have characterized a form of mAChR mediated long-term depression (LTD) at glutamatergic synapses of layer 5 principal neurons in the adult medial PFC. This mAChR LTD is induced with the mAChR agonist carbachol and inhibited by selective M1 mAChR antagonists. In contrast to other cortical regions, we find that this M1 mAChR mediated LTD is coupled to endogenous cannabinoid (eCB) signaling. Inhibition of the principal eCB CB1 receptor blocked carbachol induced LTD in both rats and mice. Furthermore, when challenged with a sub-threshold carbachol application, LTD was induced in slices pretreated with the monoacylglycerol lipase (MAGL) inhibitor JZL184, suggesting that the eCB 2-arachidonylglyerol (2-AG) mediates M1 mAChR LTD. Yet, when endogenous acetylcholine was released from local cholinergic afferents in the PFC using optogenetics, it failed to trigger eCB-LTD. However coupling patterned optical and electrical stimulation to generate local synaptic signaling allowed the reliable induction of LTD. The light—electrical pairing induced LTD was M1 mAChR and CB1 receptor mediated. This shows for the first time that connecting excitatory synaptic activity with coincident endogenously released acetylcholine controls synaptic gain via eCB signaling. Together these results shed new light on the mechanisms of synaptic plasticity in the adult PFC and expand on the actions of endogenous cholinergic signaling.
Collapse
Affiliation(s)
- Henry G S Martin
- Aix-Marseille Université Marseille, France ; Institut de Neurobiologie de la Méditerranée UMR_S 901 Marseille, France ; INMED UMR_S 901 Marseille, France
| | - Axel Bernabeu
- Aix-Marseille Université Marseille, France ; Institut de Neurobiologie de la Méditerranée UMR_S 901 Marseille, France ; INMED UMR_S 901 Marseille, France ; APHM, CHU Conception, Service de Psychiatrie Marseille, France
| | - Olivier Lassalle
- Aix-Marseille Université Marseille, France ; Institut de Neurobiologie de la Méditerranée UMR_S 901 Marseille, France ; INMED UMR_S 901 Marseille, France
| | - Clément Bouille
- Aix-Marseille Université Marseille, France ; Institut de Neurobiologie de la Méditerranée UMR_S 901 Marseille, France ; INMED UMR_S 901 Marseille, France
| | - Corinne Beurrier
- Aix-Marseille Université Marseille, France ; Centre National de la Recherche Scientifique, Institut de Biologie du Développement de Marseille UMR 7288 Marseille, France
| | - Anne-Laure Pelissier-Alicot
- Aix-Marseille Université Marseille, France ; Institut de Neurobiologie de la Méditerranée UMR_S 901 Marseille, France ; INMED UMR_S 901 Marseille, France ; APHM, CHU Timone Adultes, Service de Médecine Légale Marseille, France
| | - Olivier J Manzoni
- Aix-Marseille Université Marseille, France ; Institut de Neurobiologie de la Méditerranée UMR_S 901 Marseille, France ; INMED UMR_S 901 Marseille, France
| |
Collapse
|
21
|
Baillif-Couniou V, Kintz P, Sastre C, Pok PRP, Chèze M, Pépin G, Leonetti G, Pelissier-Alicot AL. Hair testing in postmortem diagnosis of substance abuse: An unusual case of slow-release oral morphine abuse in an adolescent. J Forensic Leg Med 2015; 36:172-6. [DOI: 10.1016/j.jflm.2015.08.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2015] [Revised: 08/24/2015] [Accepted: 08/27/2015] [Indexed: 10/23/2022]
|
22
|
Alvarez JC, Boyer JC, Verstraete AG, Pelissier-Alicot AL. Conduite automobile et cocaïne : bases bibliographiques pour un consensus de la Société française de toxicologie analytique. Toxicologie Analytique et Clinique 2015. [DOI: 10.1016/j.toxac.2015.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Karsinti E, Jarroir M, Zerdazi EH, Bloch V, Dupuy G, Belforte B, Coeuru P, Plat A, Deschenau A, Cottencin O, Gay A, Lack P, Pelissier-Alicot AL, Bellivier F, Lépine JP, Brousse G, Vorspan F. Childhood trauma are not associated with the intensity of transient cocaine induced psychotic symptoms. Psychiatry Res 2015; 228:941-4. [PMID: 26154812 DOI: 10.1016/j.psychres.2015.05.065] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Revised: 04/29/2015] [Accepted: 05/25/2015] [Indexed: 10/23/2022]
Abstract
A personal history of childhood trauma has been associated with the severity of psychotic symptoms in several disorders. We evaluated retrospectively cocaine-induced psychotic symptoms with the SAPS-CIP and childhood trauma with the CTQ in a clinical sample of 144 cocaine users. The SAPS-CIP score was not statistically associated with the presence or number or intensity of trauma, but was associated with rapid routes of administration (intravenous and smoked) and with frequent cocaine use.
Collapse
Affiliation(s)
- Emily Karsinti
- Inserm Umr_s 1144 Variabilité de Réponse aux Psychotropes, Université Paris Descartes, Université Paris Diderot, PRES Sorbonne Paris Cité, France
| | - Marine Jarroir
- APHP, Hôpital Fernand Widal, Service de Psychiatrie, CSAPA Espace Murger, Paris, France
| | - El-Hadi Zerdazi
- Inserm Umr_s 1144 Variabilité de Réponse aux Psychotropes, Université Paris Descartes, Université Paris Diderot, PRES Sorbonne Paris Cité, France
| | - Vanessa Bloch
- Inserm Umr_s 1144 Variabilité de Réponse aux Psychotropes, Université Paris Descartes, Université Paris Diderot, PRES Sorbonne Paris Cité, France
| | - Gaël Dupuy
- APHP, Hôpital Fernand Widal, Service de Psychiatrie, CSAPA Espace Murger, Paris, France
| | - Beatriz Belforte
- APHP, Hôpital Européen Georges Pompidou, CSAPA Monte-Cristo, Paris, France
| | | | - Arnaud Plat
- APHP, Hôpital Beaujon, UTAMA, Clichy, France
| | - Alice Deschenau
- Hôpital Paul Guiraud, CSAPA Clinique Liberté, Ivry-sur-Seine, France
| | | | - Aurelia Gay
- CHU St Etienne, Service d'Addictologie, Saint Etienne, France
| | | | | | - Frank Bellivier
- Inserm Umr_s 1144 Variabilité de Réponse aux Psychotropes, Université Paris Descartes, Université Paris Diderot, PRES Sorbonne Paris Cité, France; APHP, Hôpital Fernand Widal, Service de Psychiatrie, CSAPA Espace Murger, Paris, France; APHP, Hôpital Fernand Widal, Service de Médecine Addictologique, Paris, France
| | - Jean-Pierre Lépine
- Inserm Umr_s 1144 Variabilité de Réponse aux Psychotropes, Université Paris Descartes, Université Paris Diderot, PRES Sorbonne Paris Cité, France; APHP, Hôpital Fernand Widal, Service de Psychiatrie, CSAPA Espace Murger, Paris, France
| | - George Brousse
- CHU Clermont-Ferrand, Hôpital Gabriel Montpied, Service d'Addictologie et Université d'Auvergne EA 7280, UFR de Médecine, Place Henri Dunant, Clermont-Ferrand, France
| | - Florence Vorspan
- Inserm Umr_s 1144 Variabilité de Réponse aux Psychotropes, Université Paris Descartes, Université Paris Diderot, PRES Sorbonne Paris Cité, France; APHP, Hôpital Fernand Widal, Service de Médecine Addictologique, Paris, France.
| |
Collapse
|
24
|
Bartoli C, Berland-Benhaim C, Sastre C, Baillif-Couniou V, Kintz P, Leonetti G, Pelissier-Alicot AL. Off-Label Prescribing by Psychiatrists: What is the Practitioner's Liability? J Forensic Sci 2015; 60:1461-6. [PMID: 26260136 DOI: 10.1111/1556-4029.12814] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2014] [Accepted: 09/01/2014] [Indexed: 12/13/2022]
Abstract
In psychiatry, the molecules available and the dosages recommended when a drug receives marketing authorization are not always adequate to treat patients with major behavioral disturbances. Off-label prescribing is frequent in this context, with regard to the indications and the dosages given as well as to the drug combinations used. However, if complications or death occur, the practitioner's liability may be engaged. The authors report three deaths attributed to off-label prescribing in psychiatry and which led to charges against the physicians. They review the precautions to be taken when prescribing in such conditions (no other possible treatment, existence of sound scientific evidence, consent obtained from the patient, or their legal representatives except in cases of force majeure) and the physician's liability if adverse events occur that could be attributed to off-label prescribing.
Collapse
Affiliation(s)
| | | | - Caroline Sastre
- AP-HM, Hôpital de la Timone, Institut de Médecine Légale, 13385, Marseille, France
| | | | - Pascal Kintz
- X-Pertise Consulting, 42 rue Principale, 67206, Mittelhausbergen, France
| | - Georges Leonetti
- Aix-Marseille Université, 13284, Marseille, France.,AP-HM, Hôpital de la Timone, Institut de Médecine Légale, 13385, Marseille, France
| | - Anne-Laure Pelissier-Alicot
- Aix-Marseille Université, 13284, Marseille, France.,AP-HM, Hôpital de la Timone, Institut de Médecine Légale, 13385, Marseille, France
| |
Collapse
|
25
|
Sastre C, Baillif-Couniou V, Kintz P, Cirimele V, Bartoli C, Christia-Lotter MA, Piercecchi-Marti MD, Leonetti G, Pelissier-Alicot AL. Fatal Accidental Hydrogen Sulfide Poisoning: A Domestic Case. J Forensic Sci 2012; 58 Suppl 1:S280-4. [DOI: 10.1111/1556-4029.12015] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2011] [Revised: 12/21/2011] [Accepted: 01/02/2012] [Indexed: 11/27/2022]
Affiliation(s)
- Caroline Sastre
- Service de Médecine Légale; Faculté de Médecine; Université de la Mediterranée; 27 Bd Jean Moulin; 13385; Marseille Cedex 05; France
| | - Valérie Baillif-Couniou
- Service de Médecine Légale; Faculté de Médecine; Université de la Mediterranée; 27 Bd Jean Moulin; 13385; Marseille Cedex 05; France
| | - Pascal Kintz
- X-Pertise Consulting; 42 rue Principale; 67206; Mittelhausbergen; France
| | | | - Christophe Bartoli
- Service de Médecine Légale; Faculté de Médecine; Université de la Mediterranée; 27 Bd Jean Moulin; 13385; Marseille Cedex 05; France
| | - Marie-Amandine Christia-Lotter
- Service de Médecine Légale; Faculté de Médecine; Université de la Mediterranée; 27 Bd Jean Moulin; 13385; Marseille Cedex 05; France
| | - Marie-Dominique Piercecchi-Marti
- Service de Médecine Légale; Faculté de Médecine; Université de la Mediterranée; 27 Bd Jean Moulin; 13385; Marseille Cedex 05; France
| | - Georges Leonetti
- Service de Médecine Légale; Faculté de Médecine; Université de la Mediterranée; 27 Bd Jean Moulin; 13385; Marseille Cedex 05; France
| | - Anne-Laure Pelissier-Alicot
- Service de Médecine Légale; Faculté de Médecine; Université de la Mediterranée; 27 Bd Jean Moulin; 13385; Marseille Cedex 05; France
| |
Collapse
|
26
|
Sastre C, Baillif-Couniou V, Musarella F, Bartoli C, Mancini J, Piercecchi-Marti MD, Leonetti G, Pelissier-Alicot AL. Can subclavian blood be equated with a peripheral blood sample? A series of 50 cases. Int J Legal Med 2012; 127:379-84. [PMID: 22773273 DOI: 10.1007/s00414-012-0736-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2012] [Accepted: 06/19/2012] [Indexed: 11/26/2022]
Abstract
If femoral blood is not available at autopsy, toxicological analyses, in particular blood ethanol measurements, are carried out on cardiac blood. This is known to be subject to major redistribution. We aimed to determine whether subclavian blood can be equated with a peripheral blood sample and could be used if femoral blood is not available. The study was based on 50 medicolegal autopsies in which we compared ethanol concentrations between subclavian blood, the different heart blood compartments (right and left cardiac blood), and femoral blood. Mechanisms that could lead to variations in concentration, i.e., postmortem redistribution and/or endogenous production, were also taken into account in interpreting the results. Ethanol concentrations were determined by headspace gas chromatography with a flame ionization detector. In each case, we recorded the circumstances of death, resuscitation attempts if any, degree of putrefaction, chest or abdominal trauma, and/or inhalation of gastric fluid in the airways. Ethanol concentrations in subclavian blood were found to be close to those in peripheral blood (p = 0.948) and were not influenced by the degree of putrefaction (r = 0.017, p = 0.904), gastric ethanol concentration (r = -0.011, p = 0.940), inhalation of gastric contents in the airways (p = 0.461), or cardiac resuscitation attempts (p = 0.368). We discuss the possible explanations for these findings and stress the value of sampling subclavian blood when femoral blood is not obtainable at autopsy.
Collapse
|
27
|
Bartoli C, Giocanti D, Piercecchi-Marti D, Pelissier-Alicot AL, Cianfarani F, Leonetti G. The court medical expert in France: changes in status. Med Sci Law 2006; 46:328-34. [PMID: 17191636 DOI: 10.1258/rsmmsl.46.4.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
In France the status of the court expert has undergone a significant change with the adoption of statute no. 2004-130 of 11 February 2004 and its implementing regulations no. 2004-1463 of 23 December 2004. This article looks at the two most outstanding aspects of this change in status: (i) the conditions for registering on a court of appeal list and, (ii) the practical details of the quality control of the court expert's work as exercised by the judge. The article concludes with a brief comparison with the expert witness situation in England and Wales.
Collapse
Affiliation(s)
- C Bartoli
- Service de Médecine Légale et de Droit de la Santé, Faculté de Médecine, 27, boulevard Jean Moulin, 13385 Marseille Cedex 5, France.
| | | | | | | | | | | |
Collapse
|
28
|
Piercecchi-Marti MD, Louis-Borrione C, Bartoli C, Sanvoisin A, Panuel M, Pelissier-Alicot AL, Leonetti G. Malnutrition, a Rare Form of Child Abuse: Diagnostic Criteria. J Forensic Sci 2006; 51:670-3. [PMID: 16696719 DOI: 10.1111/j.1556-4029.2006.00130.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Infantile malnutrition is often difficult to diagnose as it is rarely observed in industrialized countries. It may be associated with physical violence or occur in isolation. The essential clinical sign is height and weight retardation, but malnutrition also causes a variety of internal and bone lesions, which lead to neuropsychological sequelae and death. We report a rare case of death by malnutrition in a female child aged 6 1/2 months. The infant presented height and weight growth retardation and internal lesions related to prolonged protein-energy malnutrition (fat and muscle wasting, thymic atrophy, liver steatosis) resulting in a picture of marasmus or kwashiorkor. We detail the positive and negative criteria that established the diagnosis of abuse, whereas the parents had claimed a simple dietary error.
Collapse
|
29
|
Bartoli C, Piercecchi-Marti MD, Pelissier-Alicot AL, Cianfarani F, Leonetti G. The regional commission for medical accidents and nosocomial infections set up by French law. Med Sci Law 2005; 45:211-8. [PMID: 16117281 DOI: 10.1258/rsmmsl.45.3.211] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
The regional commission for conciliation and compensation for medical accidents, iatrogenic diseases and nosocomial infections (commission régionale de conciliation et d'indemnisation des accidents médicaux, affections iatrogènes et infections nosocomiales, CRCI) offers victims of such events the possibility of obtaining compensation without recourse to legal proceedings. We suggest various points of view about this commission set up by the French law no. 2002-303 of 4 March 2002: the composition, role and competence of the CRCI; the place of the expert's report; the opinion pronounced by the CRCI and its outcome, the compensation of victims and, finally, interaction with other procedures.
Collapse
Affiliation(s)
- C Bartoli
- Service de Médecine Légale et de Droit de la Santé, Faculté de Médecine, 27, boulevard Jean Moulin, 13385 Marseille Cedex 5, France.
| | | | | | | | | |
Collapse
|
30
|
Pelissier-Alicot AL, Coste N, Bartoli C, Piercecchi-Marti MD, Sanvoisin A, Gouvernet J, Leonetti G. Comparison of ethanol concentrations in right cardiac blood, left cardiac blood and peripheral blood in a series of 30 cases. Forensic Sci Int 2005; 156:35-9. [PMID: 16410151 DOI: 10.1016/j.forsciint.2004.12.008] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2004] [Revised: 12/04/2004] [Accepted: 12/04/2004] [Indexed: 11/20/2022]
Abstract
The aim of this study was to compare ethanol concentrations in right cardiac blood, left cardiac blood and peripheral blood. Samples were taken from a series of 30 medicolegal autopsies. Ethanol was measured by headspace GC-FID. In each case, the degree of putrefaction, chest or abdominal injury, and/or regurgitation of gastric contents into the airways were noted. Our results show that there exists in certain cases a marked increase in ethanol concentration in left cardiac blood compared with right cardiac blood and peripheral blood. In these cases, we observed (i) a high concentration of ethanol in the gastric contents and (ii) regurgitation of gastric contents into the airways. The authors discuss the post-mortem redistribution mechanisms which could explain these results and stress the value of sampling right cardiac blood at autopsy.
Collapse
|
31
|
Duffort G, Eysseric H, Deveaux M, Dumestre-Toulet V, Ghysel MH, Goullé JP, Gruson A, Kintz P, Lachatre G, Lhermitte M, Mura P, Pelissier-Alicot AL, Perrin M, Ricordel I, Turcant A, Pépin G. Étude de la stabilitéin vitrode 21 antidépresseurs et de 16 neuroleptiques dans le sang total. ACTA ACUST UNITED AC 2005. [DOI: 10.1051/ata:2005019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
32
|
Pelissier-Alicot AL, Schreiber-Deturmeny E, Simon N, Gantenbein M, Bruguerolle B. Time-of-day dependent pharmacodynamic and pharmacokinetic profiles of caffeine in rats. Naunyn Schmiedebergs Arch Pharmacol 2002; 365:318-25. [PMID: 11919657 DOI: 10.1007/s00210-001-0527-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2001] [Accepted: 12/12/2001] [Indexed: 10/27/2022]
Abstract
This study aims to investigate the effects of caffeine on the daily rhythms of heart rate (HR), body temperature (BT) and locomotor activity (LA) in rats in relation to time-of-day of administration, as well as their possible mechanisms, particularly related to caffeine pharmacokinetics. During the pharmacodynamic study, HR, BT and LA were measured every 10 min by radiotelemetry and analysed by Cosinor. This study was divided into three periods: a control period P1, a treatment period P2 and a recovery period P3. During P2, rats of the morning group ( M(tel)) received a 25 mg/kg s.c. dose of caffeine at 08.00 while rats of the evening group ( E(tel)) received the same dose of caffeine at 20.00. The pharmacokinetic study was conducted in parallel with the telemetric study and was divided into two periods: a control period P1, and a treatment period P2. During P2, animals of the morning ( M(pk)) and the evening ( E(pk)) groups received the same treatment as the animals of the telemetric study. At the last day of P2, blood samples were drawn 0.25, 0.5, 1, 2, 4, 8, 12 and 24 h after the last morning and the last evening administration in order to determine the pharmacokinetics of M(pk) and E(pk). Our results showed that morning administration of caffeine suppressed the daily rhythmicity of LA and modified the mesors and amplitudes of the HR and BT daily rhythms, while the evening administration did not suppress the daily rhythm of LA, but altered the mesors, amplitudes and acrophases of the three rhythms, indicating a chronopharmacological effect. With respect to the pharmacokinetic effects, the area under the curve (AUC) was significantly lower in rats of E(pk) compared with M(pk), due to an increase of the total plasma clearance and the volume of distribution. Our data suggest that the chronopharmacokinetic effects of caffeine may explain, at least in part, the observed caffeine-induced modifications on the daily rhythms.
Collapse
Affiliation(s)
- Anne-Laure Pelissier-Alicot
- Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine, Université de la Méditerranée, 27 Bd. Jean Moulin, 13385 Marseille Cedex 5, France
| | | | | | | | | |
Collapse
|
33
|
Pelissier-Alicot AL, Gaulier JM, Champsaur P, Marquet P. Mécanismes de la redistribution post-mortem des xénobiotiques : le point sur l'état actuel des connaissances. ACTA ACUST UNITED AC 2001. [DOI: 10.1051/ata/2002023] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|